Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

JQ Wang, Y Yang, CY Cai, QX Teng, Q Cui, J Lin… - Drug Resistance …, 2021 - Elsevier
ATP-binding cassette (ABC) transporters mediate the ATP-driven translocation of structurally
and mechanistically distinct substrates against steep concentration gradients. Among the …

ABC family transporters

X Liu - Drug transporters in drug disposition, effects and …, 2019 - Springer
The transport of specific molecules across lipid membranes is an essential function of all
living organisms. The processes are usually mediated by specific transporters. One of the …

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade

Z Chen, T Shi, L Zhang, P Zhu, M Deng, C Huang, T Hu… - Cancer letters, 2016 - Elsevier
Multidrug resistance (MDR) is a serious phenomenon employed by cancer cells which
hampers the success of cancer pharmacotherapy. One of the common mechanisms of MDR …

ATP-binding cassette efflux transporters and MDR in cancer

MS Pote, RN Gacche - Drug Discovery Today, 2023 - Elsevier
Highlights•The most common reason for the failure of the cancer treatment is the evolving
drug resistance.•The ABC transporters mainly P-gp, BCRP and MRP1 are responsible for …

The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade

RJ Kathawala, P Gupta, CR Ashby Jr, ZS Chen - Drug resistance updates, 2015 - Elsevier
ATP-binding cassette (ABC) transporters represent one of the largest and oldest families of
membrane proteins in all extant phyla from prokaryotes to humans, which couple the energy …

The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity

SL Holbeck, R Camalier, JA Crowell… - Cancer research, 2017 - AACR
To date, over 100 small-molecule oncology drugs have been approved by the FDA.
Because of the inherent heterogeneity of tumors, these small molecules are often …

Inhibitors of human ABCG2: from technical background to recent updates with clinical implications

Y Toyoda, T Takada, H Suzuki - Frontiers in pharmacology, 2019 - frontiersin.org
The ATP-binding cassette transporter G2 (ABCG2; also known as breast cancer resistance
protein, BCRP) has been suggested to be involved in clinical multidrug resistance (MDR) in …

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

S Wu, L Fu - Molecular cancer, 2018 - Springer
Multidrug resistance (MDR) triggered by ATP binding cassette (ABC) transporter such as
ABCB1, ABCC1, ABCG2 limited successful cancer chemotherapy. Unfortunately, no …

Cycloruthenated Self‐Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers

J Li, L Zeng, Z Wang, H Chen, S Fang… - Advanced …, 2022 - Wiley Online Library
The synthesis and the evaluation of the efficacy of a cycloruthenated complex, RuZ, is
reported, to overcome multi‐drug resistance (MDR) in cancer cells. RuZ can self‐assemble …

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2

CP Wu, SH Hsiao, YS Wu - Drug Resistance Updates, 2023 - Elsevier
The overexpression of the human ATP-binding cassette (ABC) transporters in cancer cells is
a common mechanism involved in developing multidrug resistance (MDR). Unfortunately …